Scarica l'app Stockscreener
0.2413
8.60%
-0.0227
Dopo l'orario di chiusura:
.28
0.0387
+16.04%
Precedente Chiudi:
$0.264
Aprire:
$0.2614
Volume 24 ore:
746.64K
Relative Volume:
0.25
Capitalizzazione di mercato:
$28.71M
Reddito:
$436.97M
Utile/perdita netta:
$-35.62M
Rapporto P/E:
-0.8089
EPS:
-0.2983
Flusso di cassa netto:
$-10.71M
1 W Prestazione:
-5.34%
1M Prestazione:
-27.32%
6M Prestazione:
-72.71%
1 anno Prestazione:
-82.89%
Intervallo 1D:
$0.241
$0.276
Intervallo di 1 settimana:
$0.2356
$0.276
Portata 52W:
$0.2356
$2.10
Accuray Inc Stock (ARAY) Company Profile
Nome
Accuray Inc
Settore
Industria
Telefono
608-824-2800
Indirizzo
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
0.2413 | 28.71M | 436.97M | -35.62M | -10.71M | -0.2983 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-13 | Iniziato | ROTH MKM | Buy |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Loop Capital | Buy |
| 2020-01-21 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-11-01 | Aggiornamento | Citigroup | Sell → Neutral |
| 2017-12-13 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Iniziato | Lake Street | Buy |
| 2016-12-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Iniziato | Citigroup | Sell |
| 2015-05-01 | Reiterato | Dougherty & Company | Buy |
| 2015-01-12 | Iniziato | Northland Capital | Outperform |
| 2014-01-31 | Reiterato | Dougherty & Company | Buy |
| 2014-01-29 | Reiterato | Brean Capital | Buy |
| 2013-11-11 | Reiterato | Dougherty & Company | Buy |
| 2013-08-29 | Reiterato | Dougherty & Company | Buy |
| 2011-09-20 | Reiterato | Ticonderoga | Buy |
| 2010-02-08 | Aggiornamento | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Aggiornamento | UBS | Sell → Neutral |
| 2009-03-09 | Downgrade | Soleil | Buy → Hold |
| 2009-01-30 | Aggiornamento | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Reiterato | Jefferies & Co | Hold |
| 2008-08-20 | Reiterato | Jefferies & Co | Hold |
Mostra tutto
Accuray Inc Borsa (ARAY) Ultime notizie
Accuray(ARAY) Stock Options Chain | Quotes & News - Moomoo
Accuray Company Profile & Introduction - Moomoo
ARAY Suspends Rating by BTIG -- Maintains Neutral Outlook - GuruFocus
Neuberger Berman holds 5.1% of Accuray (NASDAQ: ARAY) — 6.07M shares - Stock Titan
Accuray (ARAY) Q1 2026 Earnings: Significant EPS Miss Sends Shares LowerEarnings Revision Downgrade - dars.gov.et
Accuray stock tumbles after earnings miss, guidance withdrawal - MSN
Accuray (ARAY) Stock Sees Fair Value Cut After Downgrades And Lower Growth Assumptions - Yahoo Finance
Accuray Incorporated Actuals & Estimates (NASDAQ:ARAY) - TradingView
Accuray Incorporated Actuals & Estimates (BX:XEJ) - TradingView
Enterprise value to EBIT forward of Accuray Incorporated – LSE:0H8I - TradingView
Accuray Incorporated Actuals & Estimates (MUN:XEJ) - TradingView
XEJ Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Accuray Incorporated – LSE:0H8I - TradingView
Price to book forward of Accuray Incorporated – NASDAQ:ARAY - TradingView
Enterprise value to EBITDA forward of Accuray Incorporated – NASDAQ:ARAY - TradingView
Enterprise value to EBIT forward of Accuray Incorporated – NASDAQ:ARAY - TradingView
Enterprise value to revenue forward of Accuray Incorporated – LSE:0H8I - TradingView
ARAY Forecast — Price Target — Prediction for 2027 - TradingView
Accuray Inc (ARAY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Accuray Inc (ARAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Accuray Inc (ARAY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Accuray Inc (ARAY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Accuray Inc (ARAY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Accuray Inc (ARAY) Institutional Confidence - TradingKey
Accuray Inc (ARAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Accuray Inc (ARAY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Accuray Inc (ARAY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
[144] ACCURAY INC SEC Filing - Stock Titan
ARAY News | ACCURAY INC (NASDAQ:ARAY) - ChartMill
Accuray (NASDAQ: ARAY) fully repays $18M 3.75% notes at maturity - Stock Titan
ARAY Stock Price, Quote & Chart | ACCURAY INC (NASDAQ:ARAY) - ChartMill
Accuray (NASDAQ: ARAY) grants SVP Paul Miele 650,000 restricted stock units - Stock Titan
Accuray Incorporated reports inducement award under Nasdaq Listing Rules - marketscreener.com
Accuray Incorporated Reports Inducement Award Under Nasdaq Listing Rules - TradingView
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules - PR Newswire
ARAY - Finviz
Accuray Stock Nearly Hit 50 Cents — Then the Rally Faded - Bez Kabli
TCW Group boosts Accuray (ARAY) stake to 13.7% through loan-linked warrants - Stock Titan
TCW Group (NASDAQ: ARAY) affiliates receive Accuray warrants tied to term loan - Stock Titan
Accuray Earnings Call Balances Turnaround Gains, Risks - The Globe and Mail
Accuray brings AI in radiotherapy to ESTRO stage focusing on clinical performance and ethics - Traders Union
Accuray showcases Radixact system for paediatric radiotherapy at ESTRO conference - Traders Union
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Accuray and University of Wisconsin launch 10-year deal to advance personalized cancer radiation therapy. - Pluang
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer - PR Newswire
TradingKey - TradingKey
News Flash: 2 Analysts Think Accuray Incorporated (NASDAQ:ARAY) Earnings Are Under Threat - Moomoo
Accuray Shares Fall After Jefferies Downgrade - Moomoo
Accuray Inc (ARAY) Runs Into Middle East Headwinds, But Shift Plan Is Working - Insider Monkey
Accuray, Aevex, Zoetis - TradingView
Jefferies Downgrades Accuray(ARAY.US) to Hold Rating, Cuts Target Price to $0.35 - 富途牛牛
Accuray Inc Azioni (ARAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Accuray Inc Azioni (ARAY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Peralta Leonel | SVP, Chief Operations Officer |
Feb 28 '26 |
Option Exercise |
0.00 |
83,723 |
0 |
83,723 |
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
2.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):